ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,203Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 298

$523K Total Retail Price of All Prescriptions

Rank: 25 out of 298

526 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 526 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 526 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,530 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 568 548 1 1
OMEPRAZOLE 422 403 2 3
AMLODIPINE BESYLATE 403 394 3 6
FUROSEMIDE 333 296 4 5
WARFARIN SODIUM 322 312 5 7
SIMVASTATIN 297 294 6 2
METOPROLOL TARTRATE 274 241 7 9
CRESTOR 264 238 8 26
POTASSIUM CHLORIDE 227 224 9 11
METOPROLOL SUCCINATE 226 199 10 12
HYDROCODONE-ACETAMINOPHEN 225 188 S3 11 8
HYDROCHLOROTHIAZIDE 216 197 12 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 214 214 13 30
LISINOPRIL 198 185 14 4
ALENDRONATE SODIUM 159 159 15 21
TAMSULOSIN HCL 157 146 16 24
ATORVASTATIN CALCIUM 155 151 17 14
CITALOPRAM HBR 152 130 18 17
DIGOXIN 149 144 19 27
CARVEDILOL 147 122 20 23
ALLOPURINOL 144 142 21 28
ATENOLOL 127 127 22 16
ZOLPIDEM TARTRATE 126 115 23 25
TRIAMTERENE-HCTZ 124 124 24 43
DONEPEZIL HCL 123 123 25 22
METFORMIN HCL 122 82 26 10
SPIRONOLACTONE 110 110 27 34
MIRTAZAPINE 110 110 27 37
GABAPENTIN 106 85 29 20
SERTRALINE HCL 106 96 29 19
SPIRIVA 103 103 31 55
DOXAZOSIN MESYLATE 101 101 32 77
PREDNISONE 89 89 33 33
NAMENDA 89 89 33 35
DILTIAZEM 24HR CD 87 87 35 74
METFORMIN HCL ER 82 80 36 57
TRAMADOL HCL 81 68 37 15
GLIPIZIDE 80 80 38 69
ADVAIR DISKUS 78 78 39 46
SULFAMETHOXAZOLE-TRIMETHOPRIM 77 72 40 118
DIOVAN 73 73 41 47
LOSARTAN POTASSIUM 70 66 42 18
DOXYCYCLINE HYCLATE 70 67 42 168
GLIMEPIRIDE 65 59 44 60
POLYETHYLENE GLYCOL 3350 62 62 45 29
TRIAMCINOLONE ACETONIDE 59 57 46 123
NEXIUM 57 56 47 40
FENTANYL 57 56 S2 47 32
BUMETANIDE 55 55 49 71
BENAZEPRIL HCL 55 55 49 52
LOSARTAN-HYDROCHLOROTHIAZIDE 53 53 51 44
ISOSORBIDE MONONITRATE ER 50 50 52 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.